Trends in cause-specific mortality among people with and without diabetes in high-income settings: a multinational, population-based study [0.03%]
高收入国家糖尿病患者与非糖尿病人群死因别死亡率趋势的跨国群组研究
Dianna J Magliano,Jedidiah I Morton,Lei Chen et al.
Dianna J Magliano et al.
Background: Cardiovascular disease has historically been the most common cause of death (COD) among people with and without diabetes. However, substantial progress has been made in the management of cardiovascular disease...
Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study [0.03%]
库欣病成功手术后的复发风险及其与USP8基因型和肿瘤大小的关联：一项国际回顾性队列研究
Qilin Zhang,Yixin Cai,Yuyu Liu et al.
Qilin Zhang et al.
Background: Recurrence after successful pituitary surgery remains a challenge in the management of patients with Cushing's disease, with no reliable predictors of long-term outcome. Pathogenic somatic USP8 variants are fo...
Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic β-cell function pretransplant [0.03%]
三种自身免疫性糖尿病和移植前内源性胰岛β细胞功能完全丧失的受者中自体和同种异体干细胞系来源的胰岛素疗法
Yongquan Shi,Yifan Feng,Tuo Li et al.
Yongquan Shi et al.
Additional benefits of combining GLP-1 receptor agonist use with lifestyle modification [0.03%]
GLP-1受体激动剂与生活方式干预联合应用的额外益处
Stefano Del Prato,Anna Solini
Stefano Del Prato
Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes: a prospective cohort study [0.03%]
在2型糖尿病患者中GLP-1受体激动剂与健康生活方式对心血管结局的联合影响：一项前瞻性队列研究
Xuan-Mai T Nguyen,Yanping Li,Sébastien Czernichow et al.
Xuan-Mai T Nguyen et al.
Background: The long-term combined effects of lifestyle habits and GLP-1 receptor agonists on cardiovascular outcomes are unknown. We aimed to examine the combined association of GLP-1 receptor agonist use and adherence t...
Lorenzo Piemonti
Lorenzo Piemonti
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid closed-loop systems. Despite near-normog...
Ram Jagannathan,Lisa R Staimez,K M Venkat Narayan
Ram Jagannathan